In AML, significantly reduced GCNT2 was found in the three independent datasets (GSE13159, 542 AML vs. 74 normal, P = 9.7e-19; GSE30029, 90 AML vs. 31 normal, P = 1.0e-4; GSE24006, 23 AML vs. 31 normal, P = 1.8e-15), (Figures 1C–E). Here, GCNT2 is linked to acute myeloid leukemia.